Tim McCarthy, CEO of ImmuPharma, talks to Proactive Investor on the successful £3.55m fundraising, giving validation of new corporate strategy from Lupuzor™ partner Avion Pharmaceuticals

21st December 2021 - 10:49 am
Share this article